DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ advanced 1.16% to $8.72 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.83% to 19,218.17 and the Dow Jones Industrial Average rising 0.42% to 44,910.65.
The stock's rise snapped a two-day losing streak.
Novavax Inc. closed $15.14 short of its 52-week high ($23.86), which the company reached on June 6th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.25% to $155.01, Pfizer Inc. $(PFE)$ rose 1.47% to $26.21, and Merck & Co. Inc. $(MRK)$ fell 1.44% to $101.64.
Trading volume (1.7 M) remained 4.7 million below its 50-day average volume of 6.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 29, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 29, 2024 17:29 ET (22:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。